BioScrip (BIOS) Posts Q3 EPS of $0.14, Tops by 4c
More News related to BIOS
- BioScrip, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference
- BioScrip, Inc. to Present at Credit Suisse 18th Annual Healthcare Conference
- BioScrip (BIOS) Posts Q3 EPS of $0.14, Tops by 4c
- Trading Radar for 10/30: Sony (SNE), Penske (PAG), Alcatel-Lucent (ALU) Report
- Trading Review for Allion Healthcare Inc. Issued by Beacon Equity
More News related to Earnings
- West Pharmaceutical Services (WST) Announces Resignation of COO
- rue21 (RUE) Appoints Arnold S. Barron to Board of Directors
- Builders FirstSource (BLDR) Appoints M. Chad Crow as New Chief Financial Officer
- MICROS Systems (MCRS) Announces Retirement of CFO; Cynthia A. Russo Named as Successor
- XL Capital (XL) Names W. Myron Hendry to New Position of Chief Platform Officer
BioScrip (NASDAQ: BIOS) reports Q3 EPS of $0.14, 4 cents better than the analyst estimate of $0.10. Revenue for the quarter was $359.40 million, which compares to the estimate of $335.58 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
